サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1434789

アルボウイルス検査市場：タイプ、成分、適応症、エンドユーザー別-2024-2030年の世界予測

Arbovirus Testing Market by Type (Enzyme-linked Immunosorbent Assays (ELISAs), RT-PCR Assays), Component (Instruments & Equipments, Laboratory Consumables, Software & Data Management Solutions), Indication, End-User - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 188 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
アルボウイルス検査市場：タイプ、成分、適応症、エンドユーザー別-2024-2030年の世界予測
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 188 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アルボウイルス検査市場規模は2023年に12億4,000万米ドルと推計され、2024年には13億1,000万米ドルに達し、CAGR 5.81%で2030年には18億5,000万米ドルに達すると予測されます。

アルボウイルス検査の世界市場

主な市場の統計
基準年[2023］ 12億4,000万米ドル
予測年[2024］ 13億1,000万米ドル
予測年 [2030] 18億5,000万米ドル
CAGR（%） 5.81%
アルボウイルス検査 Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスはアルボウイルス検査市場を評価する上で極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、アルボウイルス検査市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-アルボウイルス検査市場の市場規模および予測は？

2-アルボウイルス検査市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-アルボウイルス検査市場における技術動向と規制の枠組みは？

4-アルボウイルス検査市場における主要ベンダーの市場シェアは？

5-アルボウイルス検査市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 人口におけるアルボウイルスの有病率の上昇
      • 経済全体でヘルスケアへの意識と支出が高まる
    • 抑制要因
      • アルボウイルス検査メソッドに関連する精度の問題
    • 機会
      • 蚊媒介デング熱を撲滅するための新しい検査モデルの進化
      • 近代化されたヘルスケアインフラへの急速な投資
    • 課題
      • アルボウイルス検査の厳格な承認プロセス
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 アルボウイルス検査市場：タイプ別

  • 酵素結合免疫吸着検定法（ELISA）
  • RT-PCRアッセイ

第7章 アルボウイルス検査市場：コンポーネント別

  • 機器と装置
  • 実験用消耗品
  • ソフトウェアおよびデータ管理ソリューション

第8章 アルボウイルス検査市場適応症別

  • チクングニア熱
  • デング熱
  • 西ナイル熱
  • 黄熱病ウイルス
  • ジカ熱

第9章 アルボウイルス検査市場：エンドユーザー別

  • 診断センター
  • 病院
  • 調査機関

第10章 南北アメリカのアルボウイルス検査市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋地域のアルボウイルス検査市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第12章 欧州・中東・アフリカのアルボウイルス検査市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析

第14章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • Abbott Laboratories
    • Abnova Corporation
    • Bio-Rad Laboratories, Inc.
    • Biogenix Inc. Pvt. Ltd.
    • Biolab Diagnostics{I}Pvt. Ltd.
    • bioMerieux SA
    • Certest Biotec, S.L.
    • Creative Diagnostics
    • Diasorin S.p.A.
    • EUROIMMUN Medizinische Labordiagnostika AG
    • F. Hoffmann-La Roche Ltd.
    • Getein Biotech, Inc.
    • Hologic, Inc.
    • InBios International, Inc.
    • Intec Products, Inc.
    • Lexicare Pharma Pvt. Ltd.
    • NovaTec Immundiagnostica GmbH
    • OriGene Technologies, Inc.
    • PerkinElmer, Inc.
    • Quest Diagnostics
    • Reckon Diagnostics Pvt. Ltd.
    • Response Biomedical Corporation
    • SD Biosensor Inc.
    • Siemens Healthineers AG
    • Thermo Fisher Scientific Inc.
  • 主要な製品ポートフォリオ

第15章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. ARBOVIRUS TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. ARBOVIRUS TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. ARBOVIRUS TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ARBOVIRUS TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. ARBOVIRUS TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ARBOVIRUS TESTING MARKET DYNAMICS
  • FIGURE 7. ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
  • FIGURE 10. ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 12. ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 14. ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS ARBOVIRUS TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS ARBOVIRUS TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES ARBOVIRUS TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES ARBOVIRUS TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC ARBOVIRUS TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC ARBOVIRUS TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ARBOVIRUS TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ARBOVIRUS TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. ARBOVIRUS TESTING MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 24. ARBOVIRUS TESTING MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. ARBOVIRUS TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. ARBOVIRUS TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ARBOVIRUS TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. ARBOVIRUS TESTING MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAYS (ELISAS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ARBOVIRUS TESTING MARKET SIZE, BY RT-PCR ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 9. ARBOVIRUS TESTING MARKET SIZE, BY INSTRUMENTS & EQUIPMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. ARBOVIRUS TESTING MARKET SIZE, BY LABORATORY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. ARBOVIRUS TESTING MARKET SIZE, BY SOFTWARE & DATA MANAGEMENT SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 13. ARBOVIRUS TESTING MARKET SIZE, BY CHIKUNGUNYA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. ARBOVIRUS TESTING MARKET SIZE, BY DENGUE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. ARBOVIRUS TESTING MARKET SIZE, BY WEST NILE FEVER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. ARBOVIRUS TESTING MARKET SIZE, BY YELLOW FEVER VIRUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. ARBOVIRUS TESTING MARKET SIZE, BY ZIKA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. ARBOVIRUS TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. ARBOVIRUS TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. ARBOVIRUS TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS ARBOVIRUS TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES ARBOVIRUS TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC ARBOVIRUS TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA ARBOVIRUS TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM ARBOVIRUS TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM ARBOVIRUS TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM ARBOVIRUS TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM ARBOVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. ARBOVIRUS TESTING MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 191. ARBOVIRUS TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 192. ARBOVIRUS TESTING MARKET LICENSE & PRICING
目次
Product Code: MRR-69324464D111

[188 Pages Report] The Arbovirus Testing Market size was estimated at USD 1.24 billion in 2023 and expected to reach USD 1.31 billion in 2024, at a CAGR 5.81% to reach USD 1.85 billion by 2030.

Global Arbovirus Testing Market

KEY MARKET STATISTICS
Base Year [2023] USD 1.24 billion
Estimated Year [2024] USD 1.31 billion
Forecast Year [2030] USD 1.85 billion
CAGR (%) 5.81%
Arbovirus Testing Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Arbovirus Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Arbovirus Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Arbovirus Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abnova Corporation, Bio-Rad Laboratories, Inc., Biogenix Inc. Pvt. Ltd., Biolab Diagnostics {I}Pvt. Ltd., bioMerieux SA, Certest Biotec, S.L., Creative Diagnostics, Diasorin S.p.A., EUROIMMUN Medizinische Labordiagnostika AG, F. Hoffmann-La Roche Ltd., Getein Biotech, Inc., Hologic, Inc., InBios International, Inc., Intec Products, Inc., Lexicare Pharma Pvt. Ltd., NovaTec Immundiagnostica GmbH, OriGene Technologies, Inc., PerkinElmer, Inc., Quest Diagnostics, Reckon Diagnostics Pvt. Ltd., Response Biomedical Corporation, SD Biosensor Inc., Siemens Healthineers AG, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Arbovirus Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Enzyme-linked Immunosorbent Assays (ELISAs)
    • RT-PCR Assays
  • Component
    • Instruments & Equipments
    • Laboratory Consumables
    • Software & Data Management Solutions
  • Indication
    • Chikungunya
    • Dengue
    • West Nile Fever
    • Yellow Fever Virus
    • Zika
  • End-User
    • Diagnostic Centers
    • Hospitals
    • Research Institutes
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Arbovirus Testing Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Arbovirus Testing Market?

3. What are the technology trends and regulatory frameworks in the Arbovirus Testing Market?

4. What is the market share of the leading vendors in the Arbovirus Testing Market?

5. Which modes and strategic moves are suitable for entering the Arbovirus Testing Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Arbovirus Testing Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising rate of prevalence of arboviruses among population
      • 5.1.1.2. Growing healthcare awareness and spending across economies
    • 5.1.2. Restraints
      • 5.1.2.1. Accuracy issues associated with arbovirus testing methods
    • 5.1.3. Opportunities
      • 5.1.3.1. Evolution of new testing model to swat mosquito-borne dengue fever
      • 5.1.3.2. Rapid investments in modernized healthcare infrastructures
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent approval processes for arbovirus testing
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Arbovirus Testing Market, by Type

  • 6.1. Introduction
  • 6.2. Enzyme-linked Immunosorbent Assays (ELISAs)
  • 6.3. RT-PCR Assays

7. Arbovirus Testing Market, by Component

  • 7.1. Introduction
  • 7.2. Instruments & Equipments
  • 7.3. Laboratory Consumables
  • 7.4. Software & Data Management Solutions

8. Arbovirus Testing Market, by Indication

  • 8.1. Introduction
  • 8.2. Chikungunya
  • 8.3. Dengue
  • 8.4. West Nile Fever
  • 8.5. Yellow Fever Virus
  • 8.6. Zika

9. Arbovirus Testing Market, by End-User

  • 9.1. Introduction
  • 9.2. Diagnostic Centers
  • 9.3. Hospitals
  • 9.4. Research Institutes

10. Americas Arbovirus Testing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Arbovirus Testing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Arbovirus Testing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. Abbott Laboratories
    • 14.1.2. Abnova Corporation
    • 14.1.3. Bio-Rad Laboratories, Inc.
    • 14.1.4. Biogenix Inc. Pvt. Ltd.
    • 14.1.5. Biolab Diagnostics {I}Pvt. Ltd.
    • 14.1.6. bioMerieux SA
    • 14.1.7. Certest Biotec, S.L.
    • 14.1.8. Creative Diagnostics
    • 14.1.9. Diasorin S.p.A.
    • 14.1.10. EUROIMMUN Medizinische Labordiagnostika AG
    • 14.1.11. F. Hoffmann-La Roche Ltd.
    • 14.1.12. Getein Biotech, Inc.
    • 14.1.13. Hologic, Inc.
    • 14.1.14. InBios International, Inc.
    • 14.1.15. Intec Products, Inc.
    • 14.1.16. Lexicare Pharma Pvt. Ltd.
    • 14.1.17. NovaTec Immundiagnostica GmbH
    • 14.1.18. OriGene Technologies, Inc.
    • 14.1.19. PerkinElmer, Inc.
    • 14.1.20. Quest Diagnostics
    • 14.1.21. Reckon Diagnostics Pvt. Ltd.
    • 14.1.22. Response Biomedical Corporation
    • 14.1.23. SD Biosensor Inc.
    • 14.1.24. Siemens Healthineers AG
    • 14.1.25. Thermo Fisher Scientific Inc.
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing